Cetuximab and chemotherapy for patients with unresectable CRC liver metastasis: are we changing the natural course of the disease?
Francisco Javier
FJ
Ramos
Josep
J
Tabernero
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D000068818:Cetuximab; D002986:Clinical Trials as Topic / Q000639:trends*; D004358:Drug Therapy / Q000639:trends; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D017211:Treatment Failure; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab